Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

C Schöber; E Schmoll; H J Schmoll; H Poliwoda; F Schuppert; M Stahl; C Bokemeyer; H Wilke; J Weiss

doi:10.1016/0959-8049(92)90064-9

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

Identifier:nobleid.org/w1/20260515/CE8B2CAA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE8B2CAA.svg?ark=w1%2F20260515%2FCE8B2CAA)](https://nobleid.org/work/w1/20260515/CE8B2CAA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

Identifier:nobleid.org/w1/20260515/CE8B2CAA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE8B2CAA.svg?ark=w1%2F20260515%2FCE8B2CAA)](https://nobleid.org/work/w1/20260515/CE8B2CAA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work